Citigroup reduced its price objective for Morgan Stanley stock on October 18, 2026.
1 report, 1 independent
Updated Oct 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup reduced its price objective for Morgan Stanley stock on October 18, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Morgan Stanley
U.S. investment bank
Related events
- Citigroup reduced its price objective on Silgan shares while Royal Bank of Canada increased its price target on the company.
- Citigroup and Morgan Stanley released price target updates regarding Mercado Pago (MELI) stock.
- Multiple financial firms, including Citigroup and Truist Financial, issued rating changes, price targets, and stake acquisitions related to C. H. Robinson Worldwide.
- Citigroup reduced its price objective for ProKidney, with stock changes and ratings reported by Benzinga and MarketBeat.
- Citigroup upped its price objective and gave a 'buy' rating, while Royal Bank of Canada reissued an 'outperform' rating for Abbott Laboratories.